课题基金 / 基金详情

A transdisciplinary approach for dissecting stem cell states in prostate cancer

A transdisciplinary approach for dissecting stem cell states in prostate cancer
剖析前列腺癌干细胞状态的跨学科方法
批准号:
10491218
负责人:
Raul Rabadan
金额:
$65.89万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-20 至 2026-08-31
关键词:

项目摘要

项目成果

Raul Rabadan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Understanding the molecular mechanisms that drive prostate cancer progression has profound significance for defining the biology of lethal prostate cancer. The cancer stem cell model proposes that cells within a tumor are organized in a hierarchical lineage relationship and display different tumorigenic potential. This model has important translational implications since it suggests that effective therapeutics should target cancer stem cells that sustain tumor malignancy. However, despite intensive investigation, long-standing questions about the existence and properties of prostate cancer stem cells remain unresolved. To identify, characterize, and therapeutically target this population, we will combine the expertise of cancer stem cell researchers with computational/mathematical approaches. Leveraging techniques from theoretical physics (Random Matrix Theory) and algebraic topology (Topological Data Analysis), we will provide a statistical framework to dissect a molecular signature (termed CasPro) implicated in progenitor activity in prostate tumors. We will experimentally validate our findings by investigating CasPro-high cells in genetically-engineered mouse models of prostate cancer and analyzing their functional properties in assays of stem cell activities. These findings will then be further validated in studies of human prostate tumor samples, particularly from patients with treatment-resistant castration-resistant prostate cancer (CRPC). In the longer-term, we anticipate that our studies of key regulators of the stem cell signature as well as the epigenomic landscape of CasPro-high cells will identify novel targets for therapy, and lead to novel candidate drugs for these targets. Further development of candidate drugs might result in inhibition of cancer stem cell activity, thereby providing potential treatments for CRPC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards a quantitative understanding of tumor evolution
Towards a quantitative understanding of tumor evolution
A transdisciplinary approach for dissecting stem cell states in prostate cancer
Towards a quantitative understanding of tumor evolution
海外基金